Indaptus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 256,265 | $215,775 | 0.00% | 2.69% |
| INVESTMENT HOUSE LLC | 02/11/2025 | 100,176 | $84,358 | 0.20% | 1.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 82,118 | $69,153 | 12.29% | 0.86% |
| STRATEGY ASSET MANAGERS LLC | 02/12/2025 | 45,336 | $38,177 | 0.00% | 0.48% |
| PINE VALLEY INVESTMENTS LTD LIABILITY CO | 02/04/2025 | 43,921 | $36,986 | -0.14% | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 27,700 | $23,326 | 2.21% | 0.29% |
| VIVALDI CAPITAL MANAGEMENT LP | 02/14/2025 | 24,000 | $22,200 | 0.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 17,829 | $15,012 | 100.00% | 0.19% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 16,620 | $13,996 | 100.00% | 0.17% |
| STATE STREET CORP | 02/14/2025 | 13,073 | $11,007 | 0.00% | 0.14% |
| 02/06/2025 | 3,900 | $3,284 | 100.00% | 0.04% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,513 | $2,958 | -27.00% | 0.04% |
| UBS GROUP AG | 02/14/2025 | 2,523 | $2,124 | 383.33% | 0.03% |
| BANGOR SAVINGS BANK | 01/07/2025 | 400 | $337 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 64 | $54 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 19 | $16 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 7 | $6 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Indaptus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Indaptus Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 256,265
INVESTMENT HOUSE LLC: 100,176
GEODE CAPITAL MANAGEMENT, LLC: 82,118
STRATEGY ASSET MANAGERS LLC: 45,336
Pine Valley Investments Ltd Liability Co: 43,921
RENAISSANCE TECHNOLOGIES LLC: 27,700
6.71% of Indaptus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 649,961 shares in the last 24 months. This purchase volume represents approximately $617,463 in transactions.